Eisai
Lynn Kramer is the current Vice President and Chief Clinical Officer for Neurology at Eisai. Prior to this, they were with Eisai Company Ltd and Eisai Inc. in various leadership roles including Executive Vice President and Chief Operating Officer at Eisai Medical Research from May 2007 to June 2009. Lynn has been instrumental in the growth and success of Eisai's Neurology business and their expertise has helped to make Eisai a leading global pharmaceutical company.
Lynn Kramer's educational career began with a BA in interdisciplinary studies from Lycoming College. Lynn then completed an MD at Hahnemann Medical College and an internship in medicine at the University of California Irvine. Currently, they are a resident neurology at the University of Virginia.
They are on a team with Masatomi Akana - SVP, Chief Government Relations Officer Global Value & Access, Sayoko Sasaki - VP, Chief IR Officer Stakeholder Communications, and Shohei Kanazawa - VP, President, Asia & Latin America Region API Solutions. Lynn Kramer reports to Haruo Naito, CEO.
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.